References
- Kawa S, Kato M, Oguchi H, Kobayashi T, Furuta S, Kanai M. Preparation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2. Scand J Gastroenterol 1991; 26: 981–92
- Kawa S, Kato M, Oguchi H, et al. Preparation and partial characterization of a pancreatic cancer-associated glycoprotein expressing CA50. Scand J Gastroenterol 1991; 26: 1307–18
- Kawa S, Oguchi H, Tokoo M, et al. A comparative study of the clinical usefulness of CA19-9, CA50, sialyl SSEA-1 and Dupan 2 for the diagnosis of pancreatic cancer used alone or in combination. Jpn J Clin Chem 1990; 19: 389–98
- Kobayashi T, Kawa S, Tokoo M, et al. Comparative study of CA50 (time-resolved fluoroimmunoassay), Span-1, and CA19-9 in the diagnosis of pancreatic cancer. Scand J Gastroenterol 1991; 26: 789–97
- Nardelli J, Byrd JC, Ho J, Fearney FJ, Tasman-Jones C, Kim YS. Pancreatic cancer mucin from xenografts of SW1990 cells: isolation, characterization, and comparison to cancer mucin. Pancreas 1988; 3: 631–41
- Yu YH, Schlossman DM, Harrison CL, et al. Coexpression of different antigenic markers on moieties that bear CA125 determinants. Cancer Res 1991; 51: 468–75
- Raju GC, Lee YS. Lectin in carcinoid tumors of the gastrointestinal tract. J Pathol 1988; 154: 263–68
- Nakayama J, Okano A, Maeda H, et al. Griffonia simplicifolia agglutin-2-binding glycoprotein as a novel carbohydrate antigen of human colonic carcinoma. Jpn J Cancer Res 1990; 81: 388–95
- Shiozawa T, Tsukahara Y, Nakayama J, Katsuyama T. Lectin histochemistry of the normal human endometrium and endometrial adenocarcinoma. Acta Histochem Cytochem 1991; 24: 233–40
- Ching CK, Rhodes JM. Identification and partial characterization of a new pancreatic cancer-related serum glycoprotein by sodium dodecyl sulfate-polyacyrlamide gel electrophoresis and lectin blotting. Gastroenterology 1988; 95: 137–42
- Ching CK, Rhodes JM. Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer. Br J Cancer 1989; 59: 949–53